BeStock  
Markets › Compare › OUST vs DNLI

OUST vs DNLI

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
OUST · Ouster$44.12 ▼ 0.61%
DNLI · Denali Therapeutics$19.91 ▼ 0.45%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4282121160200Oct 7, '25Apr 7, '26Oct 5, '26
  • OUST +35.0%
  • DNLI +33.6%

Head to head

MetricOUSTDNLI
Price$44.12$19.91
Change today▼ 0.61%▼ 0.45%
Market cap$3.18B$3.18B
Return, 3 months+0.1%-24.3%
Return, year to date+103.9%+20.6%
Return, 1 year+36.0%+30.8%
P/E (TTM)-53.2-7.0
P/B8.63.8
P/E percentile vs own 5y–68th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+38.8%+76.2%
Analyst buy share80%100%
RSI (14)6236
30-day volatility65.1%35.6%
Max drawdown, 1 year-55.2%-27.5%
Trend readStrong uptrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • DNLI is the largest of the group by market value.
  • OUST has returned the most over the past year.
  • OUST carries the lowest trailing P/E.
  • DNLI has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top